Skip to main content

Rangeley Capital, LLC

SEC CIK
0001517796
Latest filing
Aug 14, 2026

The latest 13F from Rangeley Capital, LLC covers Q2 2026 (filed Aug 14, 2026): 176 long positions worth $102.3M. The top 10 holdings make up 31.4% of the portfolio, and the largest is Driven Brands Holdings Inc. (DRVN) at 7.1%. Livermore has 7 filings on Form 13F from this institution, going back to Q4 2024.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
70
Est. +$21.9M
Added
28
Est. +$7.73M
Reduced
42
Est. −$23.2M
Sold out
27
Est. −$17.5M

Top 5 holdings

Share of this quarter's portfolio value

  1. DRVNDriven Brands Holdings Inc.
    7.1%$7.22MHistory
  2. PRTAProthena Corp Public Ltd Co
    4.0%$4.09MHistory
  3. SEGSeaport Entertainment Group Inc.
    4.0%$4.08MHistory
  4. GRNDGrindr Inc.
    3.1%$3.16MHistory
  5. STHOStar Holdings
    2.9%$2.96MHistory

Biggest buys

New and added positions, by estimated amount bought

  1. NOMDNomad Foods Ltd
    +$1.48MNewHistory
  2. MLAAMountain Lake Acquisition Corp. II
    +$1.27MNewHistory
  3. DSGRDistribution Solutions Group, Inc.
    +$1.26MAddedHistory
  4. ABVXAbivax S.A.
    +$1.20MAddedHistory
  5. RLYBRallybio Corp
    +$1.20MAddedHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. NOMDNomad Foods Ltd
    +1.44 pp0.0% → 1.4%History
  2. RLYBRallybio Corp
    +1.35 pp0.3% → 1.6%History
  3. MLAAMountain Lake Acquisition Corp. II
    +1.24 pp0.0% → 1.2%History
  4. ABVXAbivax S.A.
    +1.21 pp0.5% → 1.7%History
  5. DSGRDistribution Solutions Group, Inc.
    +1.21 pp0.5% → 1.7%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. RVMDRevolution Medicines, Inc.
    −$10.9MReducedHistory
  2. LEGLeggett & Platt Inc
    −$2.10MSold outHistory
  3. ICLRIcon PLC
    −$1.96MSold outHistory
  4. KZRKezar Life Sciences, Inc.
    −$1.80MSold outHistory
  5. DKDelek US Holdings, Inc.
    −$1.68MReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. LEGLeggett & Platt Inc
    −2.28 pp2.3% → 0.0%History
  2. ICLRIcon PLC
    −2.12 pp2.1% → 0.0%History
  3. KZRKezar Life Sciences, Inc.
    −1.95 pp2.0% → 0.0%History
  4. MCWMister Car Wash, Inc.
    −1.66 pp1.7% → 0.0%History
  5. DKDelek US Holdings, Inc.
    −1.58 pp2.9% → 1.3%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$102.3M
+$9.87M (+10.7%) vs. prior quarter
Positions
176
+43 vs. prior quarter
Top 10 concentration
31.4%
Top 10 as share of value
Turnover
30.4%
Q2 2026, one quarter
Average holding period
3.3 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q4 2024), so positions held before then are understated.

13F filings by quarter

7 quarters, going back to Q4 2024. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $116.1M (Q4 2025)

Q4 2024: $103.7MQ1 2025: $87.4MQ2 2025: $79.4MQ3 2025: $106.4MQ4 2025: $116.1MQ1 2026: $92.5MQ2 2026: $102.3M
Q4 2024Q2 2026
13F filings of Rangeley Capital, LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 14, 2026176$102.3MDRVNPRTASEGvs. Q1 2026SEC
Q1 2026May 15, 2026133$92.5MDRVNPRTASEGvs. Q4 2025SEC
Q4 2025Feb 17, 2026115$116.1MWBDGDENCLMTvs. Q3 2025SEC
Q3 2025Nov 14, 2025121$106.4MDKCLMTARVNvs. Q2 2025SEC
Q2 2025Aug 14, 202570$79.4MSAGEDKARVNvs. Q1 2025SEC
Q1 2025May 14, 202571$87.4MCLMTDKABUSvs. Q4 2024SEC
Q4 2024Feb 12, 202571$103.7MCLMTAMPYDK–SEC